779 related articles for article (PubMed ID: 34239808)
1. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
Kudo M; Kawamura Y; Hasegawa K; Tateishi R; Kariyama K; Shiina S; Toyoda H; Imai Y; Hiraoka A; Ikeda M; Izumi N; Moriguchi M; Ogasawara S; Minami Y; Ueshima K; Murakami T; Miyayama S; Nakashima O; Yano H; Sakamoto M; Hatano E; Shimada M; Kokudo N; Mochida S; Takehara T
Liver Cancer; 2021 Jun; 10(3):181-223. PubMed ID: 34239808
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).
Arii S; Sata M; Sakamoto M; Shimada M; Kumada T; Shiina S; Yamashita T; Kokudo N; Tanaka M; Takayama T; Kudo M
Hepatol Res; 2010 Jul; 40(7):667-85. PubMed ID: 20633193
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
[TBL] [Abstract][Full Text] [Related]
4. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Kudo M; Okanoue T;
Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
[TBL] [Abstract][Full Text] [Related]
5. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
Kokudo N; Takemura N; Hasegawa K; Takayama T; Kubo S; Shimada M; Nagano H; Hatano E; Izumi N; Kaneko S; Kudo M; Iijima H; Genda T; Tateishi R; Torimura T; Igaki H; Kobayashi S; Sakurai H; Murakami T; Watadani T; Matsuyama Y
Hepatol Res; 2019 Oct; 49(10):1109-1113. PubMed ID: 31336394
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
Kokudo N; Hasegawa K; Akahane M; Igaki H; Izumi N; Ichida T; Uemoto S; Kaneko S; Kawasaki S; Ku Y; Kudo M; Kubo S; Takayama T; Tateishi R; Fukuda T; Matsui O; Matsuyama Y; Murakami T; Arii S; Okazaki M; Makuuchi M
Hepatol Res; 2015 Jan; 45(2):. PubMed ID: 25625806
[TBL] [Abstract][Full Text] [Related]
7. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Hasegawa K; Takemura N; Yamashita T; Watadani T; Kaibori M; Kubo S; Shimada M; Nagano H; Hatano E; Aikata H; Iijima H; Ueshima K; Ohkawa K; Genda T; Tsuchiya K; Torimura T; Ikeda M; Furuse J; Akahane M; Kobayashi S; Sakurai H; Takeda A; Murakami T; Motosugi U; Matsuyama Y; Kudo M; Tateishi R;
Hepatol Res; 2023 May; 53(5):383-390. PubMed ID: 36826411
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009).
Namiki I; Nishiguchi S; Hino K; Suzuki F; Kumada H; Itoh Y; Asahina Y; Tamori A; Hiramatsu N; Hayashi N; Kudo M
Hepatol Res; 2010 Apr; 40(4):347-68. PubMed ID: 20394674
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.
Kokudo N; Makuuchi M
J Gastroenterol; 2009; 44 Suppl 19():119-21. PubMed ID: 19148805
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H; Nagoshi S; Akahane T; Asaoka Y; Ueno Y; Ogawa K; Kawaguchi T; Kurosaki M; Sakaida I; Shimizu M; Taniai M; Terai S; Nishikawa H; Hiasa Y; Hidaka H; Miwa H; Chayama K; Enomoto N; Shimosegawa T; Takehara T; Koike K
J Gastroenterol; 2021 Jul; 56(7):593-619. PubMed ID: 34231046
[TBL] [Abstract][Full Text] [Related]
11. Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.
Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L; Monjur TM
Otolaryngol Head Neck Surg; 2019 Aug; 161(2):195-210. PubMed ID: 31369349
[TBL] [Abstract][Full Text] [Related]
12. The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021.
Cheung TT; Yu SC; Chan SL; Poon RTP; Kwok P; Lee AS; Tai A; Tam D; Cheung CC; Lai TW; Chia NH; Law A; Shum T; Lam YK; Lau V; Lee V; Chong C; Tang CN; Yau T
Hepatobiliary Surg Nutr; 2023 Jun; 12(3):366-385. PubMed ID: 37351136
[TBL] [Abstract][Full Text] [Related]
13. Clinical Practice Guideline: Sudden Hearing Loss (Update).
Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L
Otolaryngol Head Neck Surg; 2019 Aug; 161(1_suppl):S1-S45. PubMed ID: 31369359
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based clinical practice guidelines for liver cirrhosis 2020.
Yoshiji H; Nagoshi S; Akahane T; Asaoka Y; Ueno Y; Ogawa K; Kawaguchi T; Kurosaki M; Sakaida I; Shimizu M; Taniai M; Terai S; Nishikawa H; Hiasa Y; Hidaka H; Miwa H; Chayama K; Enomoto N; Shimosegawa T; Takehara T; Koike K
Hepatol Res; 2021 Jul; 51(7):725-749. PubMed ID: 34228859
[TBL] [Abstract][Full Text] [Related]
15. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.
Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y; Okusaka T; Miyayama S; Tsuchiya K; Ueshima K; Hiraoka A; Ikeda M; Ogasawara S; Yamashita T; Minami T; Yamakado K;
Liver Cancer; 2014 Oct; 3(3-4):458-68. PubMed ID: 26280007
[TBL] [Abstract][Full Text] [Related]
16. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).
Sun HC; Zhou J; Wang Z; Liu X; Xie Q; Jia W; Zhao M; Bi X; Li G; Bai X; Ji Y; Xu L; Zhu XD; Bai D; Chen Y; Chen Y; Dai C; Guo R; Guo W; Hao C; Huang T; Huang Z; Li D; Li G; Li T; Li X; Li G; Liang X; Liu J; Liu F; Lu S; Lu Z; Lv W; Mao Y; Shao G; Shi Y; Song T; Tan G; Tang Y; Tao K; Wan C; Wang G; Wang L; Wang S; Wen T; Xing B; Xiang B; Yan S; Yang D; Yin G; Yin T; Yin Z; Yu Z; Zhang B; Zhang J; Zhang S; Zhang T; Zhang Y; Zhang Y; Zhang A; Zhao H; Zhou L; Zhang W; Zhu Z; Qin S; Shen F; Cai X; Teng G; Cai J; Chen M; Li Q; Liu L; Wang W; Liang T; Dong J; Chen X; Wang X; Zheng S; Fan J;
Hepatobiliary Surg Nutr; 2022 Apr; 11(2):227-252. PubMed ID: 35464283
[TBL] [Abstract][Full Text] [Related]
17. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.
Song P; Tang W; Hasegawa K; Kokudo N
Drug Discov Ther; 2014 Apr; 8(2):64-70. PubMed ID: 24815580
[TBL] [Abstract][Full Text] [Related]
18. Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update.
Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology
Hepatol Res; 2020 Jul; 50(7):791-816. PubMed ID: 32343477
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO).
Lu J; Zhao M; Arai Y; Zhong BY; Zhu HD; Qi XL; de Baere T; Pua U; Yoon HK; Madoff DC; Teng GJ;
Hepatobiliary Surg Nutr; 2021 Oct; 10(5):661-671. PubMed ID: 34760969
[TBL] [Abstract][Full Text] [Related]
20. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
